Literature DB >> 10702177

Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease.

E Levy1, Y Rizwan, L Thibault, G Lepage, S Brunet, L Bouthillier, E Seidman.   

Abstract

BACKGROUND: Growing evidence supports a role for peroxidation in the pathogenesis of Crohn disease (CD). The activation of inflammatory cells, the release of their mediators, and the excessive production of free radicals may affect circulating lipids.
OBJECTIVE: We examined the lipid profile, lipoprotein composition, and oxidant-antioxidant status of children with CD.
DESIGN: We studied 22 pediatric CD patients and 10 healthy control subjects.
RESULTS: The proportion of saturated and monounsaturated fatty acids in plasma of CD patients was higher but that of polyunsaturated fatty acids was lower than in control subjects. This resulted in higher ratios in CD patients of palmitoleic acid to linoleic acid (P < 0. 05) and of eicosatrienoic acid to arachidonic acid (P < 0.04), 2 established indexes of essential fatty acid deficiency. Hypocholesterolemia was noted in CD patients as a result of lower LDL-cholesterol concentrations than in control subjects (P < 0.02). Plasma apolipoproteins B (P < 0.02) and A-I (P < 0.02) were also lower in CD patients, whereas plasma triacylglycerols were higher (P < 0.005). Lipoprotein composition was altered in CD patients, with relative triacylglycerol depletion and protein enrichment in VLDL. In contrast, intermediate-density lipoprotein of CD patients was characterized by an increased percentage of triacylglycerol and protein (P < 0.005) and a reduced proportion of phospholipids (P < 0. 01). Additional abnormalities were observed in the chemical distribution of HDL(2) and HDL(3) moieties. Lipid peroxidation was documented by higher plasma malondialdehyde concentrations in CD patients (P < 0.05), accompanied by lower retinol concentrations (P < 0.02).
CONCLUSION: Disturbances in the lipid profile, in lipoprotein concentrations and composition, and in oxidant-antioxidant status occur in CD patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702177     DOI: 10.1093/ajcn/71.3.807

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  43 in total

Review 1.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Cholesterol metabolism in active Crohn's disease.

Authors:  Vladimír Hrabovský; Zdenek Zadák; Vladimír Bláha; Radomír Hyspler; Tomás Karlík; Arnost Martínek; Alice Mendlová
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

4.  Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.

Authors:  Efstratios Koutroumpakis; Claudia Ramos-Rivers; Miguel Regueiro; Jana G Hashash; Arthur Barrie; Jason Swoger; Leonard Baidoo; Marc Schwartz; Michael A Dunn; Ioannis E Koutroubakis; David G Binion
Journal:  Dig Dis Sci       Date:  2015-10-29       Impact factor: 3.199

5.  Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.

Authors:  Tomasz Dawiskiba; Stanisław Deja; Agata Mulak; Adam Ząbek; Ewa Jawień; Dorota Pawełka; Mirosław Banasik; Agnieszka Mastalerz-Migas; Waldemar Balcerzak; Krzysztof Kaliszewski; Jan Skóra; Piotr Barć; Krzysztof Korta; Kornel Pormańczuk; Przemyslaw Szyber; Adam Litarski; Piotr Młynarz
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

6.  Serum protein profiling of adults and children with Crohn disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; Aggeliki Papadopoulou; Athanassios K Anagnostopoulos; George Karamanolis; George E Theodoropoulos; Amosy M'Koma; George T Tsangaris
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

Review 7.  Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?

Authors:  Ali Rezaie; Robyn D Parker; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

8.  Oxidative stress and mitochondrial functions in the intestinal Caco-2/15 cell line.

Authors:  Rame Taha; Ernest Seidman; Genevieve Mailhot; François Boudreau; Fernand-Pierre Gendron; Jean-François Beaulieu; Daniel Ménard; Edgard Delvin; Devendra Amre; Emile Levy
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

9.  Antioxidative properties of paraoxonase 2 in intestinal epithelial cells.

Authors:  Louis-Philippe Précourt; Valérie Marcil; Thierry Ntimbane; Rame Taha; Jean-Claude Lavoie; Edgard Delvin; Ernest G Seidman; Jean-François Beaulieu; Emile Levy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

10.  Lipid and phospholipid profile after bowel resection for Crohn's disease.

Authors:  Giovanna Romanato; Marco Scarpa; Cesare Ruffolo; Raffaella Marin; Sabina Zambon; Silvia Zanoni; Silvia Basato; Teresa Filosa; Fabio Pilon; Imerio Angriman; Enzo Manzato
Journal:  Int J Colorectal Dis       Date:  2008-07-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.